On June 13, 2022, Zomedica Corp. appointed Anthony K. Blair as the Company's Chief Operating Officer, effective immediately. Mr. Blair, 61, previously served as the Company's Executive Vice President, Operations from January 2022.

Prior to joining the Company, Mr. Blair was a principal founder of BGA Mfg. Services LLC, a manufacturing and operations consulting organization since September of 2001. From July 2012 through November 2015, Mr. Blair served as the Chief Operating Officer of Cardiox Corporation, privately-held company that developed, manufactured, and marketed drug-device combination products for the structural heart and liver markets.

Mr. Blair served as VP of Manufacturing for Devicor Medical Products Inc., the parent corporation of Mammotome, a company dedicated to acquiring and growing healthcare companies from August 2011 to August 2012. From June 2004 to August 2011, Mr. Blair served as the VP of Manufacturing Operations of Neoprobe Corporation, a biomedical technology company. Mr. Blair holds a Bachelors' degree in Business Administration from Cleveland State University.

On June 13, 2022, the Company appointed Karen DeHaan-Fullerton as the Company's Chief Counsel and Corporate Secretary. Ms. DeHaan-Fullerton, 54, previously served as the Company's General Counsel from May 2022. Prior to joining the Company, Ms. DeHaan-Fullerton served as Associate General Counsel and Senior Transaction Counsel at Exactech Inc., a privately held orthopedic device manufacturer from March 2019 to May 2022.

From January 2016 to March 2019, Ms. DeHaan-Fullerton held several positions at Elanco US Inc., an animal healthcare company, including BD counsel, Counsel, North America and Assistant General Counsel. Ms. DeHaan-Fullerton holds a Bachelor of Science degree from Northeast Missouri State University, an accounting certificate from Northwestern University and a Juris Doctorate from the University of Louisville.